Gene · 27329
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Angiopoietin-2 and Angiopoietin-like Proteins with a Prospective Role in Predicting Diabetic Nephropathy. | Biomedicines | 2024 | 38790911 | PubTator, text mining | PubMed |
| The first Japanese case with familial combined hypolipidemia without any complications caused by loss-of function variants in ANGPTL3: Case report. | Heliyon | 2024 | 38699738 | PubTator, text mining | PubMed |
| Hypercholesterolemia: a literature review on management using tafolecimab: a novel member of PCSK9 monoclonal antibodies. | Ann Med Surg (Lond) | 2024 | 38694324 | PubTator, text mining | PubMed |
| Atherosclerosis Residual Lipid Risk-Overview of Existing and Future Pharmacotherapies. | J Cardiovasc Dev Dis | 2024 | 38667744 | PubTator, text mining | PubMed |
| Gene associations of lipid traits, lipid-lowering drug-target genes and endometriosis. | Reprod Biomed Online | 2024 | 38657291 | PubTator, text mining | PubMed |
| Association of a genetic variant in angiopoietin-like 3 with serum HDL-C and risk of cardiovascular disease: A study of the MASHAD cohort over 6 years. | Mol Genet Genomic Med | 2024 | 38634215 | PubTator, text mining | PubMed |
| Xanthohumol, a prenylated chalcone, regulates lipid metabolism by modulating the LXRα/RXR-ANGPTL3-LPL axis in hepatic cell lines and high-fat diet-fed zebrafish models. | Biomed Pharmacother | 2024 | 38615609 | PubTator, text mining | PubMed |
| Gene Silencing of Angiopoietin-like 3 (ANGPTL3) Induced De Novo Lipogenesis and Lipid Accumulation in Huh7 Cell Line. | Int J Mol Sci | 2024 | 38612519 | PubTator, text mining | PubMed |
Extracellular Vesicles Contribute to Viral-Induced Hepatocellular Carcinoma: Understanding Their Involvement in Viral Hepatitis and Their Potential as Biomarkers for Early Hepatocellular Carcinoma Detection. | Viral Immunol | 2024 | 38588555 | PubTator, text mining | PubMed |
| The Effect of Canagliflozin on High-Density Lipoprotein Cholesterol and Angiopoietin-Like Protein 3 in Type 2 Diabetes Mellitus. | J Diabetes Res | 2024 | 38577301 | PubTator, text mining | PubMed |
| The minor allele of ANGPTL8 rs2278426 has a protective effect against CAD in T2DM patients. | Gene | 2024 | 38552749 | PubTator, text mining | PubMed |
| In Silico Description of the Direct Inhibition Mechanism of Endothelial Lipase by ANGPTL3. | Int J Mol Sci | 2024 | 38542527 | PubTator, text mining | PubMed |
| A unified model for regulating lipoprotein lipase activity. | Trends Endocrinol Metab | 2024 | 38521668 | PubTator, text mining | PubMed |
| Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial. | Eur J Prev Cardiol | 2024 | 38484368 | PubTator, text mining | PubMed |
| ANGPTL3 is a novel HDL component that regulates HDL function. | J Transl Med | 2024 | 38462608 | PubTator, text mining | PubMed |
| Weighted burden analysis of rare coding variants in 470,000 exome-sequenced UK Biobank participants characterises effects on hyperlipidaemia risk. | J Hum Genet | 2024 | 38454133 | PubTator, text mining | PubMed |
| The Role of Genetics in Advancing Cardiometabolic Drug Development. | Curr Atheroscler Rep | 2024 | 38451435 | PubTator, text mining | PubMed |
| Hepatic Inhibition of ANGPTL3 Mimics the Molecular Hallmarks of Hypothyroidism. | Arterioscler Thromb Vasc Biol | 2024 | 38450511 | PubTator, text mining | PubMed |
| Correlation between the serum FABP4, ANGPTL3, and ANGPTL4 levels and coronary artery disease. | Clin Cardiol | 2024 | 38425231 | PubTator, text mining | PubMed |
| Pre-operative levels of angiopoietin protein-like 3 (ANGPTL3) in women diagnosed with high-grade serous carcinoma of the ovary. | Lipids Health Dis | 2024 | 38414008 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27329/papers?page=17